Skip to content
Toggle Navigation
ABOUT
About Us
Leadership & Board of Directors
Expanded Access
TECHNOLOGY
STERIWAVE
NEWS
INVESTORS
Share Price
Regulatory News
Email Alerts
Reports & Documentation
Corporate Governance
AIM Rule 26
Investor Contacts
CONTACT US
NEWS & ARTICLES
Web Master
2026-05-25T13:58:31-07:00
News
Steriwave ICU Study Outcomes Presented at CSRT2026
Search for:
Top Categories
Toggle Navigation
AMR
COVID-19
Infection Control
Steriwave
Research
Events
Ondine Presented Steriwave Data at IPC 2026
April 30, 2026
ICU Study to be Presented at 2026 CACCN Conference
April 27, 2026
University of Ottawa Heart Institute Reduces Surgical Site Infections Following Implementation of Steriwave Nasal Photodisinfection
April 23, 2026
Ondine Biomedical Announces Selection of Two Abstracts for Presentation at the 2026 World Congress on Infectious Diseases
April 22, 2026
Steriwave ICU Study Shows 39.5% Pneumonia Drop
April 13, 2026
Preparing for next phase of growth
April 13, 2026
ICU Study Accepted for Publication
April 8, 2026
Steriwave receives Innovation Product Classification by UK’s NHS for alignment with long-term NHS goals
April 8, 2026
Ondine and Mid Yorks Win Excellence in Healthcare Partnership Award
February 6, 2026
1
2
Next
Load More Posts
For Media Information
5654 & Company
+44 (0) 0791 7800 011
+44 (0) 0775 7697 357
ondinebiomedical@5654.co.uk
Page load link
Go to Top